🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ICU-Recover Box 2.0, Smart Technology for Home Monitoring of ICU Patients

RecruitingNAAges 18 Years - anyAllLeiden University Medical Center
NCT07162948 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Smart technology could improve quality of care in patients who have been admitted to the ICU and have been discharged from ICU and hospital, by early diagnosis of complications and early (ambulatory) treatment. With the ICU-Recover Box and its smart technology the investigators see new opportunities to improve patient health and to recognize early if escalation of medical care is needed. The primary objective of the pilot study is to assess the feasibility of the use of smart technology by persons that have been discharged from the ICU in the twelve months following ICU discharge.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient has been admitted to the ICU of the LUMC for \> 24 hours. * Patient has received mechanical ventilation. * Patient masters the English or Dutch language. * Patient is able to use smart technology at home. (i.e. Wi-Fi available, sufficient comprehension of smart technology). * Patient can be contacted and informed about the ICU-Recover box on one of the clinical wards of the LUMC. * Patient is discharged from a ward within the LUMC to home or an extra-hospital facility. Exclusion Criteria: * Patient is \< 18 years old. * Patient is pregnant. * Patient breastfeeds during the course of the study. * Patient is discharged for palliative care. * Patient is considered an incapacitated adult. * Patient is unwilling to sign the informed consent form. * Patient is discharged to another hospital.
💊

What it tests

  • The ICU-Recover Box: using smart technology for monitoring health status after ICU admission Pilot 2.0
📍

Where

1 site
Leiden University Medical Center
Leiden, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy